Risks Relating to Patent Acquisition and Third-Party Intellectual Property Rights
First written in FY2016. 20 of 22 entries say "Restated". Latest entry: FY2026-H1.
The whole theme swung hardest in 2026: 4 of 28 companies on the "Worse" side.
66 other companies' latest entry also says "Restated".
- FY2026-H1RestatedAnnual report
「During the interim accounting period, there were no material changes relating to the emergence of new business or other risks, or to the business and other risks described in the annual securities report for the previous fiscal year.」
The Company states that there have been no new occurrences or material changes in risks relating to obtaining patents and third-party intellectual property rights. - FY2024-Q3RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes since the previous fiscal year regarding risks related to obtaining patents and third-party intellectual property rights. - FY2024-Q2RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes since the previous fiscal year regarding risks related to obtaining patents and third-party intellectual property rights. - FY2023-Q3RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes since the previous fiscal year regarding risks related to obtaining patents and third-party intellectual property rights. - FY2023-Q1RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes since the previous fiscal year regarding risks related to obtaining patents and third-party intellectual property rights. - FY2022-Q3RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2022-Q2RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2022-Q1RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2021-Q3RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2021-Q2RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2020RestatedAnnual report
「For the research and development of new technologies going forward, the Company plans to place emphasis on protecting its technology by filing parameter patent applications defined by physicochemical constants, rather than patent applications based on formulation information. However, not all patent applications filed by the Company will necessarily be registered, and if superior research and development beyond that of the Company is conducted, this may affect the Company's business strategy. Despite conducting thorough preliminary investigations, if it is determined that products developed and sold by the Company infringe third-party intellectual property rights, or if a new patent held by another company relating to the Company's products is granted, this may affect the Company's financial results.」
The Company continues to disclose the risks associated with protecting technology through parameter patents, patent applications failing to be registered, superior third-party research and development, and infringement of intellectual property rights. - FY2020-Q1RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2019WorsenedAnnual report
「Despite conducting thorough preliminary investigations, if it is determined that products developed and sold by the Company infringe third-party intellectual property rights, or if a new patent held by another company relating to the Company's products is granted, this may affect the Company's financial results.」
In addition to the existing risks of patent applications failing to be registered and superior third-party research and development, the Company explicitly identifies the risks of determinations that its products infringe third-party intellectual property rights and of related patents held by other companies being granted. - FY2018RestatedAnnual report
「For research and development of new technologies, the Company plans to prioritize technology protection by filing parameter patents defined by physicochemical constants rather than patents based on composition information. However, not all patents it files are guaranteed to be registered, and if another company conducts superior research and development beyond the Company's own efforts, this may affect the Company's business strategy.」
The risks associated with protecting technology through parameter patents, patent applications failing to be registered, and superior third-party research and development continue to be disclosed. - FY2018-Q3RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2018-Q2RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2018-Q1RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2017RestatedAnnual report
「However, not all patents it files are guaranteed to be registered, and if another company conducts superior research and development beyond the Company's own efforts, this may affect the Company's business strategy.」
No material changes have been identified in the policy of protecting technology through parameter patents or in the risks of patent applications failing to be registered and superior third-party technology. - FY2017-Q3RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there are no material changes regarding risks related to obtaining patents and third-party intellectual property rights. - FY2017-Q2RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes since the previous fiscal year regarding risks related to obtaining patents and third-party intellectual property rights. - FY2017-Q1RestatedAnnual report
「There have been no material changes to the matters concerning “Business and Other Risks” described in the annual securities report for the previous fiscal year.」
The Company states that there have been no material changes since the previous fiscal year regarding risks related to obtaining patents and third-party intellectual property rights. - FY2016First statedAnnual report
「For research and development of new technologies, the Company plans to prioritize technology protection by filing parameter patents defined by physicochemical constants rather than patents based on composition information. However, not all patents it files are guaranteed to be registered, and if another company conducts superior research and development beyond the Company's own efforts, this may affect the Company's business strategy.」
The Company describes the background to its shift from its previous patent policy toward technology protection through parameter patents, as well as the risks of unsuccessful registration and competing technologies.